Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 23, 2026 · 4:00 PM EDT

Semnur Pharmaceuticals (SMNR) Liabilities and Shareholders Equity (2022 - 2026)

Updated

Semnur Pharmaceuticals (SMNR) reported Liabilities and Shareholders Equity of $1.94 million for Q2 2026, up 245.4% from $562,462 a year earlier but down 1.3% from the prior quarter.

Analysis

Semnur Pharmaceuticals (SMNR) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, Semnur Pharmaceuticals posted Liabilities and Shareholders Equity of $1.35 million, down 79.9% from FY2024.

  • Liabilities and Shareholders Equity has declined for three consecutive years, with a three-year compound annual growth rate of -75.0% (FY2022 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $6.68 million in FY2024 (-86.8%), $50.69 million in FY2023 (-41.3%) and $86.28 million in FY2022.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $441,882 in Q1 2022 and a high of $90.15 million in Q3 2023.
  • Year over year, Liabilities and Shareholders Equity gained in 1 of the last eight quarters, with an average decline of 45.3%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2026 (growth of 245.4%); the low point was Q2 2025 (a decline of 98.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.97 million (Q1 2026), $1.35 million (Q4 2025) and $774,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 197.43 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 135.12 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 201.13 Bn
10 Semnur Pharmaceuticals 85.18 Mn 84.92 Mn - 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Mar 31, 2026 1.97 Mn
Dec 31, 2025 1.35 Mn
Sep 30, 2025 774,000.00
Jun 30, 2025 562,462.00
Mar 31, 2025 9.15 Mn
Dec 31, 2024 6.68 Mn
Sep 30, 2024 8.92 Mn
Jun 30, 2024 52.12 Mn
Mar 31, 2024 51.35 Mn
Dec 31, 2023 50.69 Mn
Sep 30, 2023 90.15 Mn
Jun 30, 2023 88.19 Mn
Mar 31, 2023 86.96 Mn
Dec 31, 2022 86.28 Mn
Sep 30, 2022 85.76 Mn
Jun 30, 2022 85.53 Mn
Mar 31, 2022 441,882.00
API Access

Semnur Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SMNR&period=max&api_key=YOUR_API_KEY